Antiviral Research

Editorial board
pp. CO2-CO2(1)

Biochemical characterization of rhinovirus RNA-dependent RNA polymerase
pp. 99-114(16)
Authors: Hung M.; Gibbs C.S.; Tsiang M.

Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors
pp. 115-127(13)
Authors: Hurwitz S.J.; Schinazi R.F.

Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance
pp. 129-142(14)
Authors: Loemba H.; Brenner B.; Parniak M.A.; Ma'ayan S.; Spira B.; Moisi D.; Oliveira M.; Detorio M.; Essex M.; Wainberg M.A.

Antiviral agents alter ability of HSV-2 to disrupt gap junctional intercellular communication between mammalian cells in vitro
pp. 143-151(9)
Authors: Musee J.; Mbuy G.N.K.; Woodruff R.I.

Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs
pp. 153-166(14)
Author: Marcelletti J.F.

Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox - Novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea
pp. 167-181(15)
Authors: Mayhew C.N.; Mampuru L.J.; Chendil D.; Ahmed M.M.; Phillips J.D.; Greenberg R.N.; Elford H.L.; Gallicchio V.S.

Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice
pp. 183-188(6)
Authors: Kurokawa M.; Tsurita M.; Brown J.; Fukuda Y.; Shiraki K.